215 related articles for article (PubMed ID: 20348243)
21. Sex-Specific MicroRNAs in Neurovascular Units in Ischemic Stroke.
Florijn BW; Bijkerk R; Kruyt ND; van Zonneveld AJ; Wermer MJH
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769320
[TBL] [Abstract][Full Text] [Related]
22. Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications.
Otmani K; Lewalle P
Front Oncol; 2021; 11():708765. PubMed ID: 34722255
[TBL] [Abstract][Full Text] [Related]
23. CRISPR/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancer.
Deepak Singh D; Han I; Choi EH; Yadav DK
Comput Struct Biotechnol J; 2021; 19():2384-2397. PubMed ID: 34025931
[TBL] [Abstract][Full Text] [Related]
24. The Heterogeneity of Breast Cancer Metabolism.
Tan J; Le A
Adv Exp Med Biol; 2021; 1311():89-101. PubMed ID: 34014536
[TBL] [Abstract][Full Text] [Related]
25. The Role of Long Non-Coding RNA NNT-AS1 in Neoplastic Disease.
Zhou C; Duan S
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33113895
[TBL] [Abstract][Full Text] [Related]
26. Androgen downregulation of miR-760 promotes prostate cancer cell growth by regulating IL6.
Wang S; Yang Y; Cao YD; Tang XX; Du P
Asian J Androl; 2021; 23(1):85-90. PubMed ID: 32415054
[TBL] [Abstract][Full Text] [Related]
27. ERα-related chromothripsis enhances concordant gene transcription on chromosome 17q11.1-q24.1 in luminal breast cancer.
Lin CL; Tan X; Chen M; Kusi M; Hung CN; Chou CW; Hsu YT; Wang CM; Kirma N; Chen CL; Lin CH; Lathrop KI; Elledge R; Kaklamani VG; Mitsuya K; Huang TH
BMC Med Genomics; 2020 May; 13(1):69. PubMed ID: 32408897
[TBL] [Abstract][Full Text] [Related]
28. CXXC5 as an unmethylated CpG dinucleotide binding protein contributes to estrogen-mediated cellular proliferation.
Ayaz G; Razizadeh N; Yaşar P; Kars G; Kahraman DC; Saatci Ö; Şahin Ö; Çetin-Atalay R; Muyan M
Sci Rep; 2020 Apr; 10(1):5971. PubMed ID: 32249801
[TBL] [Abstract][Full Text] [Related]
29. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
[TBL] [Abstract][Full Text] [Related]
30. The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.
Nassa G; Giurato G; Salvati A; Gigantino V; Pecoraro G; Lamberti J; Rizzo F; Nyman TA; Tarallo R; Weisz A
Sci Data; 2019 Sep; 6(1):173. PubMed ID: 31527615
[TBL] [Abstract][Full Text] [Related]
31. Temporal dynamic reorganization of 3D chromatin architecture in hormone-induced breast cancer and endocrine resistance.
Zhou Y; Gerrard DL; Wang J; Li T; Yang Y; Fritz AJ; Rajendran M; Fu X; Stein G; Schiff R; Lin S; Frietze S; Jin VX
Nat Commun; 2019 Apr; 10(1):1522. PubMed ID: 30944316
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of histone methyltransferase DOT1L silences ERα gene and blocks proliferation of antiestrogen-resistant breast cancer cells.
Nassa G; Salvati A; Tarallo R; Gigantino V; Alexandrova E; Memoli D; Sellitto A; Rizzo F; Malanga D; Mirante T; Morelli E; Nees M; Åkerfelt M; Kangaspeska S; Nyman TA; Milanesi L; Giurato G; Weisz A
Sci Adv; 2019 Feb; 5(2):eaav5590. PubMed ID: 30775443
[TBL] [Abstract][Full Text] [Related]
33. H19X-encoded miR-424(322)/-503 cluster: emerging roles in cell differentiation, proliferation, plasticity and metabolism.
Wang F; Liang R; Tandon N; Matthews ER; Shrestha S; Yang J; Soibam B; Yang J; Liu Y
Cell Mol Life Sci; 2019 Mar; 76(5):903-920. PubMed ID: 30474694
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms for estrogen receptor expression in human cancer.
Hua H; Zhang H; Kong Q; Jiang Y
Exp Hematol Oncol; 2018; 7():24. PubMed ID: 30250760
[TBL] [Abstract][Full Text] [Related]
35. Pleiotropic functions of miR107 in cancer networks.
Luo Z; Zheng Y; Zhang W
Onco Targets Ther; 2018; 11():4113-4124. PubMed ID: 30140157
[TBL] [Abstract][Full Text] [Related]
36. Breast Cancer Metabolism.
Tan J; Le A
Adv Exp Med Biol; 2018; 1063():83-93. PubMed ID: 29946777
[TBL] [Abstract][Full Text] [Related]
37. Estrogen-induced miR-196a elevation promotes tumor growth and metastasis via targeting SPRED1 in breast cancer.
Jiang CF; Shi ZM; Li DM; Qian YC; Ren Y; Bai XM; Xie YX; Wang L; Ge X; Liu WT; Zhen LL; Liu LZ; Jiang BH
Mol Cancer; 2018 Apr; 17(1):83. PubMed ID: 29685157
[TBL] [Abstract][Full Text] [Related]
38. Polymorphism rs2682818 in miR-618 is associated with colorectal cancer susceptibility in a Han Chinese population.
Chen Y; Du M; Chen W; Zhu L; Wu C; Zhang Z; Wang M; Chu H; Gu D; Chen J
Cancer Med; 2018 Apr; 7(4):1194-1200. PubMed ID: 29533012
[TBL] [Abstract][Full Text] [Related]
39. Break Breast Cancer Addiction by CRISPR/Cas9 Genome Editing.
Yang H; Jaeger M; Walker A; Wei D; Leiker K; Weitao T
J Cancer; 2018; 9(2):219-231. PubMed ID: 29344267
[TBL] [Abstract][Full Text] [Related]
40. Post-menopausal breast cancer: from estrogen to androgen receptor.
Majumder A; Singh M; Tyagi SC
Oncotarget; 2017 Nov; 8(60):102739-102758. PubMed ID: 29254284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
